Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cigna ( (CI) ) has issued an announcement.
At The Cigna Group’s Annual Meeting of Shareholders held on April 22, 2026, approximately 90% of outstanding shares were represented, and shareholders elected all 12 director nominees to one-year terms, signaling continued support for the existing board. Investors also gave advisory approval to the company’s executive compensation program and ratified PricewaterhouseCoopers LLP as independent auditor for 2026, while a shareholder proposal to grant the right to act by written consent failed to gain majority backing, reinforcing the current governance framework.
The strong turnout and broad backing of management-sponsored proposals suggest stability in The Cigna Group’s leadership and oversight structure, which may reassure stakeholders about continuity in strategic direction. The rejection of the written-consent initiative preserves the existing shareholder rights regime, indicating that a majority of investors are comfortable with current mechanisms for influencing corporate decisions and oversight.
The most recent analyst rating on (CI) stock is a Buy with a $330.00 price target. To see the full list of analyst forecasts on Cigna stock, see the CI Stock Forecast page.
Spark’s Take on CI Stock
According to Spark, TipRanks’ AI Analyst, CI is a Outperform.
The score is driven primarily by solid fundamentals and cash generation, supported by an attractive valuation (low-teens P/E plus dividend). Technicals are constructive with positive momentum. Offsetting factors include margin/medical cost pressure and near-term cash flow headwinds tied to the PBM transition, alongside execution considerations during the CEO handover.
To see Spark’s full report on CI stock, click here.
More about Cigna
The Cigna Group is a global health services company operating in the health care and insurance industry, offering medical, pharmacy, behavioral health, dental and related benefit products and services. The company focuses on serving employers, government organizations and individuals with integrated health solutions designed to improve access, affordability and health outcomes.
Average Trading Volume: 1,730,117
Technical Sentiment Signal: Sell
Current Market Cap: $72.68B
Learn more about CI stock on TipRanks’ Stock Analysis page.